Sanara MedTech

Update in progress

SMTI (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Instruments & Supplies

Sanara MedTech Inc. is a Fort Worth, Texas-based medical technology company that develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care providers in the United States. Its portfolio includes CellerateRX Surgical, a bovine collagen hydrolysate for wound management; BIASURGE and BIASURGE Advanced Surgical Solution; FORTIFY TRG; BiFORM; ACTIGEN; ALLOCYTE Plus; and TEXAGEN. It licenses Rochal antimicrobial products.

Company score

Sentiment: 0.00; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.02; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.06; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.01; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.00; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive